Literature DB >> 7759776

In vitro immunotoxicity and cytotoxicity of trichosanthin against human normal immunocytes and leukemia-lymphoma cells.

Y T Zheng1, W F Zhang, K L Ben, J H Wang.   

Abstract

Trichosanthin (TCS) is a ribosome-inactivating protein from root tubers of Trichosanthes kirilowii Maxim. In this paper, the effects of TCS on the viability of human peripheral blood immunocytes, on the proliferation of lymphocytes, and its cytotoxicity to twelve cell lines of lymphoma or leukemia had been observed. TCS at high concentration (> 12.5 micrograms/ml) affected the viability of human B lymphocytes, but not that of human peripheral blood mononuclear cells (PBMCs), T lymphocytes and granulocytes. Human peripheral blood-derived monocytes/macrophages were highly sensitive to TCS (ID50 at 1.70 micrograms/ml). TCS suppressed lymphocyte proliferation stimulated by Concanavalin A (Con A) or lipopolysaccharide (LPS). Human T cell lines and macrophage cell lines were more sensitive (ID50 < 0.9 microgram/ml) to TCS than B cell lines and myeloid lines. These results suggest that selective cytotoxicity of TCS to human macrophages/monocytes may be implicated in anti-HIV activity, and that selectively killing some leukemia-lymphoma cells by TCS merit further evaluation in treatment of some lymphoma and leukemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7759776     DOI: 10.3109/08923979509052721

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  9 in total

1.  Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.

Authors:  Jean-San Chia; Jia-Ling Du; Wei-Bin Hsu; Andy Sun; Chun-Pin Chiang; Won-Bo Wang
Journal:  BMC Cancer       Date:  2010-04-30       Impact factor: 4.430

2.  Evaluation of Cynanchum otophyllum glucan sulfate against human immunodeficiency virus and herpes simplex virus as a microbicide agent.

Authors:  Jian Tao; Jing Yang; Chaoyin Chen; Xiaomei Cao; Shenglan Zhao; Kunlong Ben
Journal:  Indian J Pharmacol       Date:  2011-09       Impact factor: 1.200

3.  Design and Synthesis of Novel N-Arylsulfonyl-3-(2-yl-ethanone)-6-methylindole Derivatives as Inhibitors of HIV-1 Replication.

Authors:  Zhiping Che; Shengming Liu; Yuee Tian; Zhenjie Hu; Yingwu Chen; Genqiang Chen
Journal:  Pharmaceuticals (Basel)       Date:  2015-05-08

4.  Trichosanthin suppresses the proliferation of glioma cells by inhibiting LGR5 expression and the Wnt/β-catenin signaling pathway.

Authors:  Junjie Miao; Yilin Jiang; Dongliang Wang; Jingru Zhou; Cungang Fan; Feng Jiao; Bo Liu; Jun Zhang; Yangshuo Wang; Qingjun Zhang
Journal:  Oncol Rep       Date:  2015-09-18       Impact factor: 3.906

5.  The anti-HIV actions of 7- and 10-substituted camptothecins.

Authors:  Yu-Ye Li; Shi-Wu Chen; Liu-Meng Yang; Rui-Rui Wang; Wei Pang; Yong-Tang Zheng
Journal:  Molecules       Date:  2009-12-31       Impact factor: 4.411

Review 6.  Structural and Functional Investigation and Pharmacological Mechanism of Trichosanthin, a Type 1 Ribosome-Inactivating Protein.

Authors:  Wei-Wei Shi; Kam-Bo Wong; Pang-Chui Shaw
Journal:  Toxins (Basel)       Date:  2018-08-20       Impact factor: 4.546

7.  Lyophyllin, a Mushroom Protein from the Peptidase M35 Superfamily Is an RNA N-Glycosidase.

Authors:  Jia-Qi Lu; Wei-Wei Shi; Meng-Jie Xiao; Yun-Sang Tang; Yong-Tang Zheng; Pang-Chui Shaw
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

Review 8.  Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review.

Authors:  Ou Sha; Junfei Niu; Tzi-Bun Ng; Eric Yu-Pang Cho; Xiaoyuan Fu; Wenqi Jiang
Journal:  Cancer Chemother Pharmacol       Date:  2013-02-03       Impact factor: 3.333

Review 9.  A Sixty-Year Research and Development of Trichosanthin, a Ribosome-Inactivating Protein.

Authors:  Jia-Qi Lu; Kam-Bo Wong; Pang-Chui Shaw
Journal:  Toxins (Basel)       Date:  2022-02-27       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.